U.S. Markets closed
  • S&P Futures

    3,595.50
    +19.50 (+0.55%)
     
  • Dow Futures

    29,735.00
    +189.00 (+0.64%)
     
  • Nasdaq Futures

    11,954.00
    +48.75 (+0.41%)
     
  • Russell 2000 Futures

    1,831.90
    +14.80 (+0.81%)
     
  • Crude Oil

    43.15
    +0.09 (+0.21%)
     
  • Gold

    1,824.30
    -13.50 (-0.73%)
     
  • Silver

    23.39
    -0.24 (-1.03%)
     
  • EUR/USD

    1.1847
    +0.0001 (+0.0118%)
     
  • 10-Yr Bond

    0.8570
    +0.0280 (+3.38%)
     
  • Vix

    22.66
    -1.04 (-4.39%)
     
  • GBP/USD

    1.3328
    +0.0006 (+0.0440%)
     
  • USD/JPY

    104.5430
    +0.0550 (+0.0526%)
     
  • BTC-USD

    18,403.91
    +144.18 (+0.79%)
     
  • CMC Crypto 200

    368.62
    +7.19 (+1.99%)
     
  • FTSE 100

    6,333.84
    -17.61 (-0.28%)
     
  • Nikkei 225

    26,199.77
    +672.40 (+2.63%)
     

BioMarin to Participate in Upcoming Virtual Investor Conference

·1 min read

- Morningstar's Management Behind the Moat Conference on September 30 at 1:00pm ET

SAN RAFAEL, Calif., Sept. 29, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Brian Mueller, Executive Vice President, Chief Financial Officer, will participate in Morningstar's Management Behind the Moat Conference on September 30, 2020 at 1:00pm ET. An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)
BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:


Investors

Media

Traci McCarty

Debra Charlesworth

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 455-7558

(415) 455-7451

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-upcoming-virtual-investor-conference-301139652.html

SOURCE BioMarin Pharmaceutical Inc.